Over 60 million Americans have heartburn at least once a month. Chances are, you're one of these Americans.
Anthony A. Starpoli, MD | www.starpoli.com
0 Comments
Reflux, acid reflux, sleep disturbance, TIF, fundoplication, LINX, GERD, LPR, EsophyX, esophageal cancer, endoscopic sleeve gastrectomy, Barrett's Esophagus, Stretta
Gastroesophageal Reflux Disease (GERD) is a life-affecting condition that affects as many as 20% of the population. Given the prevalence of GERD, the quest for suitable treatment methods has been a relentless one— but often to little effect.
Anthony A. Starpoli, MD | www.starpoli.com
Obesity, Reflux, fundoplication, atypical reflux, heartburn, EsophyX, incisionless surgery, GERD Awareness Week
As reported by Medscape, according to research presented at the Digestive Disease Week meeting, “patients with gastroesophageal reflux disease (GERD) might benefit more from transoral incisionless fundoplication (TIF) than from continued treatment with proton-pump inhibitors (PPIs).” The study’s lead author Karim Trad, MD, said, “In this study, transoral incisionless fundoplication was superior to maximal-dose PPIs in eliminating daily troublesome typical and atypical symptoms in selected patients.” Dr. Trad added that the findings “establish for the first time that, for some patients, the procedure is better than maximal-dose PPI therapy for controlling a range of GERD symptoms.”
Anthony A. Starpoli, MD | www.starpoli.com
hiatal hernia, fundoplication, LINX, GERD, atypical reflux, EsophyX, incisionless surgery, esophageal cancer
On September 7th and October 13th, 2011, the first two combined laparoscopic and transoral antireflux procedures were performed at the New York Univerisity Langone Medical Center in New York City.
Anthony A. Starpoli, MD | www.starpoli.com
Reflux, hiatal hernia, TIF, fundoplication, GERD, LPR, atypical reflux, heartburn, EsophyX, Barrett's Esophagus
A report was published in the May 18 issue ofA report was published in the May 18 issue of Journal of the American Medical Association. In, what is referred to as the LOTUS (Long-Term Usage of Esomeprazole vs Surgery for Treatment of Chronic GERD) study, remission rates at five years were 92% (95% CI 89 to 96) for patients on esomeprazole and 85% (95% CI 81 to 90, P=0.048) for those who had laparoscopic antireflux surgery, according to Jean-Paul Galmiche, MD, of Nantes University in France, and colleagues.
Anthony A. Starpoli, MD | www.starpoli.com
